Dissemin is shutting down on January 1st, 2025

Published in

Life Science Alliance, Life Science Alliance, 2(7), p. e202302461, 2023

DOI: 10.26508/lsa.202302461

Links

Tools

Export citation

Search in Google Scholar

PD-L1 regulates inflammatory programs of macrophages from human pluripotent stem cells

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Red circle
Postprint: archiving forbidden
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO

Abstract

Programmed death ligand 1 (PD-L1) serves as a pivotal immune checkpoint in both the innate and adaptive immune systems. PD-L1 is expressed in macrophages in response to IFNγ. We examined whether PD-L1 might regulate macrophage development. We established PD-L1 KO (CD274-/-) human pluripotent stem cells and differentiated them into macrophages and observed a 60% reduction in CD11B+CD45+macrophages inCD274-/-; this was orthogonally verified, with the PD-L1 inhibitor BMS-1166 reducing macrophages to the same fold. Single-cell RNA sequencing further confirmed the down-regulation of the macrophage-defining transcription factorsSPI1andMAFB. Furthermore,CD274-/-macrophages reduced the level of inflammatory signals such as NF-κB and TNF, and chemokine secretion of the CXCL and CCL families. Anti-inflammatory TGF-β was up-regulated. Finally, we identified thatCD274-/-macrophages significantly down-regulated interferon-stimulated genes despite the presence of IFNγ in the differentiation media. These data suggest that PD-L1 regulates inflammatory programs of macrophages from human pluripotent stem cells.